[{"edinetCode":"E32146","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":67.0,"averageTemporaryStaff":6.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":659020.0,"sharesOwendPercent":0.5523,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":5286.48,"equityRatio":0.45,"cashAndCashEquivalents":1118292000.0,"assets":14008134000.0,"currentAssets":7940332000.0,"fixedAsset":6067801000.0,"tangibleFixedAssets":220503000.0,"intangibleFixedAssets":29044000.0,"investmentAndOtherAssets":5818253000.0,"liabilities":7701384000.0,"currentLiabilities":4756325000.0,"shorTermDept":33855000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":300000000.0,"fixedLiabilities":2945058000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1350000000.0,"netAsset":6306750000.0,"capitalStock":3027928000.0,"capital":248169000.0,"capitalSurplus":176361000.0,"accumulatedEarnings":2603487000.0,"treasuryStock":-89000.0,"valuationAndConversionAdjustments":3278822000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":18828258000.0,"costOfSales":17273051000.0,"grossProfit":1555207000.0,"sgaExpenses":1257586000.0,"salaryAndBenefit":516706000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":297620000.0,"nonOperatingIncome":143285000.0,"nonOperatingExpenses":51745000.0,"interestExpense":14963000.0,"ordinaryProfit":389161000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":389161000.0,"incomeTaxes":127669000.0,"netIncome":261491000.0,"netIncomeAttributableToOwnersOfTheParentCompany":261491000.0,"comprehensiveIncome":415321000.0,"eps":219.18,"dilutedEps":null,"dividendPerShare":null,"per":10.5,"roe":0.043,"cashFlowFromOperatingActivities":66316000.0,"depreciationAndCashflowFromOperatingActivities":11996000.0,"cashFlowFromInvestingActivities":-102679000.0,"cashFlowFromFinancialActivities":-215493000.0,"changesInCashAndCashEquivalents":-245407000.0,"列1":"asr","submitDate":"2017\/6\/29","stockCode":3537,"accountingYear":"第57期(自　平成28年４月１日　至　平成29年３月31日)","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":69.0,"averageTemporaryStaff":6.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":683220.0,"sharesOwendPercent":0.5727,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":6424.61,"equityRatio":0.447,"cashAndCashEquivalents":1824291000.0,"assets":17131937000.0,"currentAssets":9513230000.0,"fixedAsset":7618707000.0,"tangibleFixedAssets":208406000.0,"intangibleFixedAssets":30618000.0,"investmentAndOtherAssets":7379682000.0,"liabilities":9467925000.0,"currentLiabilities":6633336000.0,"shorTermDept":34925000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":600000000.0,"fixedLiabilities":2834588000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":750000000.0,"netAsset":7664012000.0,"capitalStock":3288365000.0,"capital":248169000.0,"capitalSurplus":176361000.0,"accumulatedEarnings":2864175000.0,"treasuryStock":-341000.0,"valuationAndConversionAdjustments":4375646000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":20198883000.0,"costOfSales":18567766000.0,"grossProfit":1631116000.0,"sgaExpenses":1296384000.0,"salaryAndBenefit":525780000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":334731000.0,"nonOperatingIncome":140801000.0,"nonOperatingExpenses":23976000.0,"interestExpense":13756000.0,"ordinaryProfit":451556000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":451556000.0,"incomeTaxes":137183000.0,"netIncome":314373000.0,"netIncomeAttributableToOwnersOfTheParentCompany":314373000.0,"comprehensiveIncome":1411197000.0,"eps":263.52,"dilutedEps":null,"dividendPerShare":null,"per":12.1,"roe":0.045,"cashFlowFromOperatingActivities":1105957000.0,"depreciationAndCashflowFromOperatingActivities":24690000.0,"cashFlowFromInvestingActivities":-39690000.0,"cashFlowFromFinancialActivities":-353935000.0,"changesInCashAndCashEquivalents":705998000.0,"列1":"asr","submitDate":"2018\/6\/27","stockCode":3537,"accountingYear":"第58期(自　平成29年４月１日　至　平成30年３月31日)","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":72.0,"averageTemporaryStaff":7.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2086760.0,"sharesOwendPercent":0.5831,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":2258.1,"equityRatio":0.48,"cashAndCashEquivalents":1629485000.0,"assets":16831265000.0,"currentAssets":8782207000.0,"fixedAsset":8049057000.0,"tangibleFixedAssets":193869000.0,"intangibleFixedAssets":23677000.0,"investmentAndOtherAssets":7831511000.0,"liabilities":8750694000.0,"currentLiabilities":6284071000.0,"shorTermDept":332643000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":450000000.0,"fixedLiabilities":2466623000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":300000000.0,"netAsset":8080570000.0,"capitalStock":3494962000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3073937000.0,"treasuryStock":-711000.0,"valuationAndConversionAdjustments":4585607000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":20110251000.0,"costOfSales":18482744000.0,"grossProfit":1627506000.0,"sgaExpenses":1353634000.0,"salaryAndBenefit":546289000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":273872000.0,"nonOperatingIncome":157465000.0,"nonOperatingExpenses":19890000.0,"interestExpense":11425000.0,"ordinaryProfit":411446000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":411446000.0,"incomeTaxes":138460000.0,"netIncome":272986000.0,"netIncomeAttributableToOwnersOfTheParentCompany":272986000.0,"comprehensiveIncome":482946000.0,"eps":76.53,"dilutedEps":null,"dividendPerShare":null,"per":13.1,"roe":0.035,"cashFlowFromOperatingActivities":331942000.0,"depreciationAndCashflowFromOperatingActivities":25031000.0,"cashFlowFromInvestingActivities":-33348000.0,"cashFlowFromFinancialActivities":-505213000.0,"changesInCashAndCashEquivalents":-194806000.0,"列1":"asr","submitDate":"2019\/6\/28","stockCode":3537,"accountingYear":"第59期(自　2018年４月１日　至　2019年３月31日)","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.494,"cashAndCashEquivalents":null,"assets":15883075000.0,"currentAssets":8132602000.0,"fixedAsset":7750472000.0,"tangibleFixedAssets":210537000.0,"intangibleFixedAssets":21802000.0,"investmentAndOtherAssets":7518132000.0,"liabilities":8041884000.0,"currentLiabilities":5664850000.0,"shorTermDept":33269000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":450000000.0,"fixedLiabilities":2377034000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":300000000.0,"netAsset":7841190000.0,"capitalStock":3461400000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3040374000.0,"treasuryStock":-711000.0,"valuationAndConversionAdjustments":4379790000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":4497372000.0,"costOfSales":4123392000.0,"grossProfit":373980000.0,"sgaExpenses":344852000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":29127000.0,"nonOperatingIncome":26952000.0,"nonOperatingExpenses":7046000.0,"interestExpense":1562000.0,"ordinaryProfit":49033000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":49033000.0,"incomeTaxes":18184000.0,"netIncome":30849000.0,"netIncomeAttributableToOwnersOfTheParentCompany":30849000.0,"comprehensiveIncome":-174967000.0,"eps":8.62,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/8","stockCode":3537,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2107445.0,"sharesOwendPercent":0.5889,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.527,"cashAndCashEquivalents":859528000.0,"assets":14796492000.0,"currentAssets":7346120000.0,"fixedAsset":7450372000.0,"tangibleFixedAssets":213687000.0,"intangibleFixedAssets":19928000.0,"investmentAndOtherAssets":7216756000.0,"liabilities":6996516000.0,"currentLiabilities":5006545000.0,"shorTermDept":352299000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":450000000.0,"fixedLiabilities":1989970000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7799976000.0,"capitalStock":3585913000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3164887000.0,"treasuryStock":-711000.0,"valuationAndConversionAdjustments":4214062000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":9057549000.0,"costOfSales":8285785000.0,"grossProfit":771764000.0,"sgaExpenses":685480000.0,"salaryAndBenefit":241250000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":86283000.0,"nonOperatingIncome":90363000.0,"nonOperatingExpenses":11926000.0,"interestExpense":3797000.0,"ordinaryProfit":164721000.0,"extraordinaryGain":57619000.0,"extraordinaryLoss":null,"incomeBeforeTax":222340000.0,"incomeTaxes":66977000.0,"netIncome":155362000.0,"netIncomeAttributableToOwnersOfTheParentCompany":155362000.0,"comprehensiveIncome":-216181000.0,"eps":43.42,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-513054000.0,"depreciationAndCashflowFromOperatingActivities":11785000.0,"cashFlowFromInvestingActivities":85485000.0,"cashFlowFromFinancialActivities":-343807000.0,"changesInCashAndCashEquivalents":-769956000.0,"列1":"q2r","submitDate":"2019\/11\/8","stockCode":3537,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.508,"cashAndCashEquivalents":null,"assets":16443265000.0,"currentAssets":8231023000.0,"fixedAsset":8212241000.0,"tangibleFixedAssets":211908000.0,"intangibleFixedAssets":18054000.0,"investmentAndOtherAssets":7982279000.0,"liabilities":8090390000.0,"currentLiabilities":5846610000.0,"shorTermDept":247205000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":300000000.0,"fixedLiabilities":2243779000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8352874000.0,"capitalStock":3586914000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3218517000.0,"treasuryStock":-53339000.0,"valuationAndConversionAdjustments":4765959000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":13579571000.0,"costOfSales":12425949000.0,"grossProfit":1153622000.0,"sgaExpenses":1028967000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":124655000.0,"nonOperatingIncome":107435000.0,"nonOperatingExpenses":13669000.0,"interestExpense":5041000.0,"ordinaryProfit":218420000.0,"extraordinaryGain":78469000.0,"extraordinaryLoss":null,"incomeBeforeTax":296890000.0,"incomeTaxes":87898000.0,"netIncome":208992000.0,"netIncomeAttributableToOwnersOfTheParentCompany":208992000.0,"comprehensiveIncome":389344000.0,"eps":58.53,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/7","stockCode":3537,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":74.0,"averageTemporaryStaff":5.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2119308.0,"sharesOwendPercent":0.6093,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":2339.0,"equityRatio":0.542,"cashAndCashEquivalents":732515000.0,"assets":14999910000.0,"currentAssets":7132918000.0,"fixedAsset":7866992000.0,"tangibleFixedAssets":207368000.0,"intangibleFixedAssets":16979000.0,"investmentAndOtherAssets":7642645000.0,"liabilities":6864473000.0,"currentLiabilities":4735857000.0,"shorTermDept":413302000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":300000000.0,"fixedLiabilities":2128615000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8135437000.0,"capitalStock":3572292000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3265465000.0,"treasuryStock":-114909000.0,"valuationAndConversionAdjustments":4563144000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":17733944000.0,"costOfSales":16225624000.0,"grossProfit":1508320000.0,"sgaExpenses":1380165000.0,"salaryAndBenefit":562974000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":128154000.0,"nonOperatingIncome":160844000.0,"nonOperatingExpenses":26895000.0,"interestExpense":6656000.0,"ordinaryProfit":262103000.0,"extraordinaryGain":101960000.0,"extraordinaryLoss":null,"incomeBeforeTax":364063000.0,"incomeTaxes":108122000.0,"netIncome":255940000.0,"netIncomeAttributableToOwnersOfTheParentCompany":255940000.0,"comprehensiveIncome":233478000.0,"eps":72.08,"dilutedEps":null,"dividendPerShare":null,"per":12.0,"roe":0.032,"cashFlowFromOperatingActivities":-472184000.0,"depreciationAndCashflowFromOperatingActivities":24762000.0,"cashFlowFromInvestingActivities":116353000.0,"cashFlowFromFinancialActivities":-547293000.0,"changesInCashAndCashEquivalents":-896969000.0,"列1":"asr","submitDate":"2020\/6\/29","stockCode":3537,"accountingYear":"第60期(自　2019年４月１日　至　2020年３月31日)","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.549,"cashAndCashEquivalents":null,"assets":14540079000.0,"currentAssets":6823015000.0,"fixedAsset":7717063000.0,"tangibleFixedAssets":203936000.0,"intangibleFixedAssets":15063000.0,"investmentAndOtherAssets":7498064000.0,"liabilities":6557264000.0,"currentLiabilities":4449933000.0,"shorTermDept":347767000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":300000000.0,"fixedLiabilities":2107330000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7982815000.0,"capitalStock":3543090000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3236262000.0,"treasuryStock":-114909000.0,"valuationAndConversionAdjustments":4439725000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":4110630000.0,"costOfSales":3745788000.0,"grossProfit":364841000.0,"sgaExpenses":333334000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":31507000.0,"nonOperatingIncome":25499000.0,"nonOperatingExpenses":3239000.0,"interestExpense":1096000.0,"ordinaryProfit":53766000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":53766000.0,"incomeTaxes":20362000.0,"netIncome":33404000.0,"netIncomeAttributableToOwnersOfTheParentCompany":33404000.0,"comprehensiveIncome":-90015000.0,"eps":9.61,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/7","stockCode":3537,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2117145.0,"sharesOwendPercent":0.61,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.551,"cashAndCashEquivalents":980612000.0,"assets":14082844000.0,"currentAssets":6786606000.0,"fixedAsset":7296237000.0,"tangibleFixedAssets":199948000.0,"intangibleFixedAssets":13146000.0,"investmentAndOtherAssets":7083142000.0,"liabilities":6318231000.0,"currentLiabilities":4353019000.0,"shorTermDept":647517000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1965211000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7764613000.0,"capitalStock":3600170000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3293343000.0,"treasuryStock":-114909000.0,"valuationAndConversionAdjustments":4164442000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":7911956000.0,"costOfSales":7206936000.0,"grossProfit":705019000.0,"sgaExpenses":651106000.0,"salaryAndBenefit":243485000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":53912000.0,"nonOperatingIncome":88566000.0,"nonOperatingExpenses":6672000.0,"interestExpense":2273000.0,"ordinaryProfit":135806000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":135806000.0,"incomeTaxes":45321000.0,"netIncome":90485000.0,"netIncomeAttributableToOwnersOfTheParentCompany":90485000.0,"comprehensiveIncome":-308217000.0,"eps":26.05,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":332680000.0,"depreciationAndCashflowFromOperatingActivities":12063000.0,"cashFlowFromInvestingActivities":42296000.0,"cashFlowFromFinancialActivities":-127019000.0,"changesInCashAndCashEquivalents":248096000.0,"列1":"q2r","submitDate":"2020\/11\/6","stockCode":3537,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.511,"cashAndCashEquivalents":null,"assets":15321677000.0,"currentAssets":8005467000.0,"fixedAsset":7316209000.0,"tangibleFixedAssets":195760000.0,"intangibleFixedAssets":11236000.0,"investmentAndOtherAssets":7109212000.0,"liabilities":7494275000.0,"currentLiabilities":5505012000.0,"shorTermDept":648484000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1989263000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7827401000.0,"capitalStock":3659707000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3352880000.0,"treasuryStock":-114909000.0,"valuationAndConversionAdjustments":4167694000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":12388029000.0,"costOfSales":11283932000.0,"grossProfit":1104097000.0,"sgaExpenses":974727000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":129369000.0,"nonOperatingIncome":105281000.0,"nonOperatingExpenses":10036000.0,"interestExpense":2988000.0,"ordinaryProfit":224614000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":224614000.0,"incomeTaxes":74592000.0,"netIncome":150022000.0,"netIncomeAttributableToOwnersOfTheParentCompany":150022000.0,"comprehensiveIncome":-245428000.0,"eps":43.19,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/5","stockCode":3537,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":74.0,"averageTemporaryStaff":3.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2023980.0,"sharesOwendPercent":0.5831,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":2202.48,"equityRatio":0.523,"cashAndCashEquivalents":1010940000.0,"assets":14605801000.0,"currentAssets":7721075000.0,"fixedAsset":6884726000.0,"tangibleFixedAssets":192559000.0,"intangibleFixedAssets":9340000.0,"investmentAndOtherAssets":6682827000.0,"liabilities":6961053000.0,"currentLiabilities":5170202000.0,"shorTermDept":699545000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1790850000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7644748000.0,"capitalStock":3747459000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3440632000.0,"treasuryStock":-114909000.0,"valuationAndConversionAdjustments":3897288000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":17032260000.0,"costOfSales":15559179000.0,"grossProfit":1473081000.0,"sgaExpenses":1315442000.0,"salaryAndBenefit":569767000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":157638000.0,"nonOperatingIncome":172288000.0,"nonOperatingExpenses":16457000.0,"interestExpense":4230000.0,"ordinaryProfit":313469000.0,"extraordinaryGain":2761000.0,"extraordinaryLoss":null,"incomeBeforeTax":316230000.0,"incomeTaxes":78456000.0,"netIncome":237774000.0,"netIncomeAttributableToOwnersOfTheParentCompany":237774000.0,"comprehensiveIncome":-428081000.0,"eps":68.47,"dilutedEps":null,"dividendPerShare":null,"per":14.2,"roe":0.03,"cashFlowFromOperatingActivities":324817000.0,"depreciationAndCashflowFromOperatingActivities":24168000.0,"cashFlowFromInvestingActivities":39014000.0,"cashFlowFromFinancialActivities":-77019000.0,"changesInCashAndCashEquivalents":278424000.0,"列1":"asr","submitDate":"2021\/6\/25","stockCode":3537,"accountingYear":"第61期(自　2020年４月１日　至　2021年３月31日)","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.505,"cashAndCashEquivalents":null,"assets":14571865000.0,"currentAssets":8066842000.0,"fixedAsset":6505023000.0,"tangibleFixedAssets":189019000.0,"intangibleFixedAssets":7780000.0,"investmentAndOtherAssets":6308223000.0,"liabilities":7211760000.0,"currentLiabilities":5515489000.0,"shorTermDept":656555000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1696271000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7360105000.0,"capitalStock":3706605000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3399778000.0,"treasuryStock":-114909000.0,"valuationAndConversionAdjustments":3653500000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":5076212000.0,"costOfSales":4691419000.0,"grossProfit":384793000.0,"sgaExpenses":356515000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":28277000.0,"nonOperatingIncome":20652000.0,"nonOperatingExpenses":3423000.0,"interestExpense":715000.0,"ordinaryProfit":45506000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":45506000.0,"incomeTaxes":23882000.0,"netIncome":21623000.0,"netIncomeAttributableToOwnersOfTheParentCompany":21623000.0,"comprehensiveIncome":-222165000.0,"eps":6.24,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/6","stockCode":3537,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2092880.0,"sharesOwendPercent":0.6057,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.509,"cashAndCashEquivalents":696865000.0,"assets":14681362000.0,"currentAssets":8158692000.0,"fixedAsset":6522670000.0,"tangibleFixedAssets":185391000.0,"intangibleFixedAssets":5865000.0,"investmentAndOtherAssets":6331412000.0,"liabilities":7213609000.0,"currentLiabilities":5507574000.0,"shorTermDept":753383000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1706035000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7467753000.0,"capitalStock":3809203000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3502376000.0,"treasuryStock":-114909000.0,"valuationAndConversionAdjustments":3658549000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":9993504000.0,"costOfSales":9209446000.0,"grossProfit":784058000.0,"sgaExpenses":677315000.0,"salaryAndBenefit":246867000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":106742000.0,"nonOperatingIncome":93024000.0,"nonOperatingExpenses":6728000.0,"interestExpense":1596000.0,"ordinaryProfit":193038000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":193038000.0,"incomeTaxes":68816000.0,"netIncome":124221000.0,"netIncomeAttributableToOwnersOfTheParentCompany":124221000.0,"comprehensiveIncome":-114517000.0,"eps":35.88,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-294089000.0,"depreciationAndCashflowFromOperatingActivities":11075000.0,"cashFlowFromInvestingActivities":-992000.0,"cashFlowFromFinancialActivities":-12477000.0,"changesInCashAndCashEquivalents":-314075000.0,"列1":"q2r","submitDate":"2021\/11\/8","stockCode":3537,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0},{"edinetCode":"E32146","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.484,"cashAndCashEquivalents":null,"assets":14950886000.0,"currentAssets":8888692000.0,"fixedAsset":6062194000.0,"tangibleFixedAssets":182429000.0,"intangibleFixedAssets":4134000.0,"investmentAndOtherAssets":5875629000.0,"liabilities":7715264000.0,"currentLiabilities":6139105000.0,"shorTermDept":53976000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1576158000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7235622000.0,"capitalStock":3910646000.0,"capital":248169000.0,"capitalSurplus":173568000.0,"accumulatedEarnings":3603818000.0,"treasuryStock":-114909000.0,"valuationAndConversionAdjustments":3324976000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":15584137000.0,"costOfSales":14353315000.0,"grossProfit":1230822000.0,"sgaExpenses":1000614000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":230207000.0,"nonOperatingIncome":116040000.0,"nonOperatingExpenses":9196000.0,"interestExpense":2481000.0,"ordinaryProfit":337051000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":337051000.0,"incomeTaxes":111387000.0,"netIncome":225664000.0,"netIncomeAttributableToOwnersOfTheParentCompany":225664000.0,"comprehensiveIncome":-346648000.0,"eps":65.22,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/8","stockCode":3537,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E32146","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":248,"settlementDate":"2022\/3\/31","submitterName":"昭栄薬品株式会社","submitterNameEnglish":"SHOEI YAKUHIN CO.,LTD.","submitterNameKana":"ショウエイヤクヒンカブシキガイシャ","location":"大阪市中央区安土町一丁目５番１号","industory":"卸売業","corporateNumber":4120000000000.0}]